Pseudoprogression and hyperprogression in lung cancer: a comprehensive review of literature.
Laiyan ZhouMai ZhangRui LiJianxin XueYou LuPublished in: Journal of cancer research and clinical oncology (2020)
Atypical response patterns, such as pseudoprogression and hyperprogression, are increasingly common in clinical practice. Immune-related response criteria can help diagnose pseudoprogression. Molecular mechanisms of hyperprogression remain unclear. Biomarkers for pseudoprogression and hyperprogression are required.
Keyphrases